A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in Healthy Subjects

Clinical trial NCT04802811 · COMPLETED

Trial details

NCT number: NCT04802811
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1 Infection

Start date: 2021-03-22
Primary completion: 2021-11-10
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.